Fundz

Australian startup Mirugen secures up to AU$4.5M seed funding for pioneering cell reprogramming.

PRIVATEAug 18, 2025

Amount Raised

A$4.5 Million

Round Type

Seed

MelbourneBiotechnologyHealth Careresearch

Description

Mirugen, an Australian startup, has successfully secured up to AU$4.5 million in seed funding. The funding will support the company's innovative endeavors in cell reprogramming technology. This investment is crucial for enhancing their research and development capabilities. The funds will allow Mirugen to advance their pioneering initiatives in the biotech sector.

Quick answer

Mirugen raised A$4.5 Million in a Seed round, dated August 18, 2025. Mirugen is based in Melbourne, Victoria, Australia.

How much did Mirugen raise?
Mirugen raised A$4.5 Million in a Seed round on August 18, 2025.
What does Mirugen do?
Mirugen is an Australian startup focused on pioneering cell reprogramming technologies.
Where is Mirugen based and how big is it?
Mirugen is based in Melbourne, Victoria, Australia. Fundz records about 3 employees.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Mirugen that raised within 45 days of this round, from Fundz verified event records.

  • SeaBeLife raised $2.3M (Pre-Series A) on October 1, 2025.
  • QuantHealth raised an undisclosed amount (Corporate Round) on October 1, 2025.
  • Aarvik Therapeutics raised an undisclosed amount (Seed) on September 29, 2025.
  • BNB Plus raised $58M on September 29, 2025.
  • Corner Therapeutics raised $17M on September 26, 2025.
  • Until Labs raised $58M (Series A) on September 22, 2025.

Who to call at Mirugen, and when

A new round usually means Mirugen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mirugen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mirugen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mirugen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mirugen

Location

Melbourne, Victoria, Australia

About

Mirugen is an Australian startup focused on pioneering cell reprogramming technologies. The company aims to innovate healthcare solutions through advanced cellular techniques. Their research and development efforts are geared towards transforming medical treatments and therapies. Mirugen is positioned to make a significant impact in the biotechnology sector.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mirugen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mirugen's next move

See what Strategic adds

Mirugen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.